NR4A2 and autism spectrum disorder: Undoubtedly, the identification of de novo NR4A2 variants among patients with intellectual disabilities and speech/motor impairments reinforces their significance in 2q23q24 microdeletion syndrome [21] and further spotlights the NR4A2 gene as a potential target for genetic testing in patients or families with autistic spectrum disorders (ASD).